Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-12-11
2007-12-11
O'Hara, Eileen B. (Department: 1646)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C536S023500, C530S350000, C435S320100, C435S325000, C435S361000, C435S252300
Reexamination Certificate
active
10380492
ABSTRACT:
A novel gene PGC-3, and its role in regulating the transcriptional activity of PPARγ in adipose tissue. PGC-3 is highly expressed in human white adipose tissue and has utility in the development of new therapeutic agents for use in the treatment of obesity and other related disorders such as non-insulin dependent diabetes mellitus, insulin resistance syndrome, dyslipidemia, and atherosclerosis.
REFERENCES:
patent: 2002/0048763 (2002-04-01), Penn et al.
patent: 2003/0171354 (2003-09-01), Wardleworth et al.
patent: 2004/0044181 (2004-03-01), Tang et al.
patent: WO97/21435 (1997-06-01), None
patent: WO97/21703 (1997-06-01), None
patent: WO97/21704 (1997-06-01), None
patent: WO97/21707 (1997-06-01), None
patent: WO98/54220 (1998-12-01), None
patent: WO98/55116 (1998-12-01), None
patent: WO98/55119 (1998-12-01), None
patent: WO98/55123 (1998-12-01), None
patent: WO98/55470 (1998-12-01), None
patent: WO98/55479 (1998-12-01), None
patent: WO99/21553 (1999-05-01), None
patent: WO99/21557 (1999-05-01), None
patent: WO99/41251 (1999-08-01), None
patent: WO99/41252 (1999-08-01), None
patent: WO99/51231 (1999-10-01), None
patent: WO99/51232 (1999-10-01), None
patent: WO99/51233 (1999-10-01), None
patent: WO99/51234 (1999-10-01), None
patent: WO99/51595 (1999-10-01), None
patent: WO99/51596 (1999-10-01), None
patent: WO 00/04013 (2000-01-01), None
patent: WO 00/32215 (2000-06-01), None
patent: WO 00/53178 (2000-09-01), None
patent: WO 00/53179 (2000-09-01), None
patent: WO 00/53180 (2000-09-01), None
patent: WO 00/53181 (2000-09-01), None
patent: WO 00/53185 (2000-09-01), None
patent: WO 00/53602 (2000-09-01), None
patent: WO 00/69433 (2000-11-01), None
patent: WO 01/57272 (2001-08-01), None
patent: WO 01/57275 (2001-08-01), None
patent: WO-02/18424 (2002-03-01), None
Esterbauer et al., Genomics (1999), vol. 62, pp. 98-102.
Lin et al., The Journal of Biological Chemistry, vol. 277, No. 3, Jan. 18, 2002, pp. 1645-1648.
Meirhaghe et al., Biochemical Journal, vol. 373, 2003, pp. 155-165.
P. Puigserver et al., “A cold-inducible coactivator of nuclear receptors linked to adaptative thermogenesis.” Cell, vol. 92, Mar. 20, 1998.
Database EMBL ′Online! Accession No. AW236547, Dec. 15, 1999 “xm47f06.x1 NCI—CGAP—GC6 homo sapiens cDNA clone IMAGE:2687363 3′ similar to TR:070343 PPAR Gamma Coactivator 1” XP002188800.
Database EMBL ′Online! Accession No. AW149754, Nov. 4, 1999 “xf41h08.x1 NCI—CGAP—Brn50 homo sapiens cDNA clone IMAGE:2620671 3′ similar to TR:070343 PPAR Gamma Coactivator 1” XP002188801.
Esterbauer et al, “Human Peroxisome Proliferator Activated Receptor Gamma Coactivator 1 (PPARGC1) Gene: cDNA Sequence, Genomic Organization, Chromosomal Localization, and Tissue Expression.” Genomics (1999), vol. 62, pp. 98-102.
Larrouy et al., “Cloning and mRNA tissue distribution of huma PPARy coactivator 1.” International Journal of Obesity (1999), vol. 23, pp. 1327-1332.
Knutti et al., “A Tissue-Specific Coactivator of Steroid Receptors, Identified in a Functional Genetic Screen.” Mol. Cell Biol. (2000), vol. 20(7), pp. 2411-2422.
Ashton, W. et al, Substituted Indole-5-carboxamides and -acetamides as Potent Nonpeptide GnRH Receptor Antagonists, Bioorganic & Medicinal Chemistry Letters 11: 1723-1726 (2001).
Ashton, W. et al, Potent Nonpeptide GnRH Receptor Antagonists Derived from Substituted Indole-5-carboxamides and -acetamides Bearing a Pyridine Side-Chain Terminus, Bioorganic & Medicinal Chemistry Letters 11: 1727-1731 (2001).
Ashton, W. et al, Orally Bioavailable, Indole-Based Nonpeptide GnRH Receptor Antagonists with High Potency and Functional Activity, Bioorganic & Medicinal Chemistry Letters 11: 2597-2602 (2001).
Chu, L. et al, SAR Studies of Novel 5-Substituted 2-Arylindoles as Nonpeptidyl GnRH Receptor Antagonists, Bioorganic & Medicinal Chemistry Letters 11: 515-517 (2001).
Chu, L. et al, Initial Structure-Activity Relationship of a Novel Class of Nonpeptidyl GnRH Receptor Antagonists: 2-Arylindoles, Bioorganic & Medicinal Chemistry Letters 11: 509-513 (2001).
Freidinger, R., Nonpeptidic ligands for peptide and protein receptors, Current Opinion in Chemical Biology 3: 395-406 (1999).
Lin, P. et al, Heterocyclic Derivatives of 2-(3,5-Dimethylphenyl) tryptamine as GnRH Receptor Antagonists, Bioorganic & Medicinal Chemistry Letters 11: 1077-1080 (2001).
Lin, P. et al, 2-(3,5-Dimethylphenyl) tryptamine Derivatives That Bind to the GnRH Receptor, Bioorganic & Medicinal Chemistry Letters 11: 1073-1076 (2001).
Goulet, M., Gonadotropin Releasing Hormone Antagonists, Annual Reports in Medicinal Chemistry 30: 169-178 (1995).
Simeone, J. et al, Synthesis of chiral β-methyl tryptamine-derived GnRH antagonists, Tetrahedron Letters 42: 6459-6461 (2001).
Ujjainwalla, F. et al, Total syntheses of 6- and 7-azaindole derived GnRH antagonists, Tetrahedron Letters 42: 6441-6445 (2001).
Walsh, T. et al, A convergent synthesis of (S)-β-methyl-2-aryltryptamine based gonadotropin releasing hormone antagonists, Tetrahedron 57: 5233-5241 (2001).
Young, J. et al, 2-Arylindoles as Gonadotropin Releasing Hormone (GnRH) Antagonists: Optimization of the Tryptamine Side Chain, Bioorganic & Medicinal Chemistry Letters 12: 827-832 (2002).
Hart Kevin Anthony
Montague Carl Thomas
Vidal-Puig Antonio
AstraZeneca AB
O'Hara Eileen B.
Ropes & Gray LLP
LandOfFree
Human and rat PGC-3, PPAR-gamma coactivations and splice... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human and rat PGC-3, PPAR-gamma coactivations and splice..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human and rat PGC-3, PPAR-gamma coactivations and splice... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3829804